|Home | About | Journals | Submit | Contact Us | Français|
Language: | French
Pancreatic pseudocysts develop in 10% to 20% of patients with chronic pancreatitis, and can cause a variety of complications such as infection, bleeding or development of fistulae. However, fistulous communication with the common bile duct is very rare. The present report describes an unusual case of a patient with a large, symptomatic pancreatic pseudocyst with a fistula to the common bile duct that was treated successfully by combined biliary and pancreatic stenting.
De 10 % à 20 % des patients atteints d’une pancréatite chronique acquièrent un pseudokyste pancréatique qui peut causer diverses complications telles qu’une infection, une hémorragie ou l’apparition de fistules. Cependant, la communication fistulaire avec le canal cholédoque est très rare. Le présent rapport décrit le cas inhabituel d’un patient ayant un gros pseudokyste pancréatique symptomatique, accompagné d’une fistule vers le canal cholédoque traitée avec succès par une endoprothèse biliaire et pancréatique combinée.
Pancreatic pseudocysts (PPs) are present in approximately 10% to 20% of patients with chronic pancreatitis, and most commonly occur in alcoholic chronic pancreatitis. Abdominal pain is the most common symptom, with nausea, vomiting, palp-able abdominal mass, bleeding and jaundice being less common findings. Complications include bleeding, common bile duct (CBD) obstruction, duodenal obstruction and external-internal pancreatic fistulae. These fistulae are found in 5% to 41% of cases. Treatment generally consists of percutaneous, endoscopic or surgical drainage for individuals with symptoms, complications or enlarging pseudocysts. We diagnosed a 42-year-old man who had a PP with a fistulous communication to the CBD. This has not been described previously, other than in a small number of case reports.
A 42-year-old Caucasian man with a history of deep vein thrombosis, heparin-induced thrombocytopenia, chronic pancreatitis secondary to alcohol abuse and a PP drained surgically five years previously, presented to Vancouver General Hospital, Vancouver, British Columbia. The patient had a two-week history of progressive jaundice, mild-to-moderate dull right upper quadrant pain and a 6 kg to 8 kg weight loss over a one-year period. The physical examination revealed a deeply jaundiced and mildly febrile patient (37.8°C). In addition, his right upper quadrant was tender, with mild hepatomegaly. The initial laboratory investigation revealed a hemoglobin level of 100 g/L, a mean corpuscular volume of 116 fL, gammaglutamyl transferase 387 U/L, alkaline phosphatase 1192 U/L, alanine aminotransferase 120 U/L, aspartate aminotransferase 206 U/L, international normalized ratio 1.27, albumin 24 g/L and direct bilirubin 180 mg/L. Radiological examination, including abdominal ultrasound and computed tomography scan, showed a relatively thin-walled, cystic mass in the region of the pancreatic head measuring 9.6 cm × 8.5 cm × 8.4 cm, causing mild pancreatic duct (4 mm to 5 mm) and CBD dilation (10 mm). In addition, there were multiple punctate pancreatic calcifications (Figure 1). Subsequently, the patient underwent endoscopic retrograde cholangiopancreatography (ERCP) that revealed a long, distal CBD stricture and a large pseudocyst in the head of the pancreas, filling via a fistulous communication with the CBD at the middle of the stricture (Figure 2). A 10 Fr, 10 cm Cotton-Leung stent (Cook Medical, USA) was placed in the CBD, and a 7 Fr, 7 cm double-pigtail stent was placed via the transpapillary route across the fistula into the pseudocyst (Figure 3). The patient was started on antibiotics and discharged home a few days later – after his symptoms dramatically improved and liver enzymes normalized. He remained pain-free without further hospitalization. A follow-up computed tomography scan of his abdomen two months later showed a dramatic resolution of the pseudocyst (Figure 4). The pigtail stent was removed during ERCP two months after the initial presentation and the biliary stent was exchanged in view of the persisting biliary stricture. ERCP performed after one further month revealed no evidence of residual fistulous communication between the CBD and the previous pseudocyst. The patient continued to do well and was scheduled for further stenting of his biliary stricture. The bile duct stricture was presumed secondary to chronic pancreatitis and to compression from the previous pseudocyst. It was unclear at this stage whether he required longer-term biliary stenting or perhaps surgery, or whether this stricture was mainly the result of a relatively inflammatory process.
PPs occur in approximately 10% to 20% of patients with chronic pancreatitis, and are most commonly seen in alcoholic chronic pancreatitis (1). PPs are persistent, peripancreatic, enzyme-rich fluid collections with a clearly defined fibrous wall but lacking a true epithelial lining (1). Pseudocysts are typically caused by disruption of the pancreatic duct with extravasation of pancreatic enzymes. Such disruption can be caused either by an acute event (trauma or stone passage) or repeated attacks of pancreatitis. Approximately 30% of acute pseudocysts resolve spontaneously; however, thick-walled chronic pseudocysts can often persist and enlarge. Both acute and chronic pseudocysts can cause serious complications such as sepsis, obstruction, hemorrhage, pancreatic ascites and, rarely, fistula formation to other viscera. The most common organs to which pseudocysts can fistulize are the stomach, duodenum, colon and, less commonly, the esophagus (2). Fistulas to the biliary tract are distinctly rare. In fact, to our knowledge, there have been only 16 cases of PPs with fistula to the CBD reported in the literature (3–15) (Table 1). Among these 16 cases, most were in men. Alcoholic chronic pancreatitis was the most common etiology, with abdominal pain being the most common clinical presentation. Ten of 16 cases were treated surgically, three patients were treated with percutaneous external drainage of the pseudocyst and one patient was observed. Only two cases were successfully treated endoscopically by placing one stent in the biliary tract and another across the fistula (14,15). Fistulous communication of a PP to the CBD is uncommon. We have demonstrated that it can be successfully managed endoscopically. It was believed that biliary stenting alone would not have been adequate because the pseudocyst was quite large, as was the size of the fistulous communication with the CBD.